Ameritas Investment Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Ameritas Investment Partners’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,887	Closed	-$16K	–	3341
2022 Q1	$16K	Hold	7,887	–	–	﹤0.01%	2658
2021 Q4	$21K	Hold	7,887	–	–	﹤0.01%	2635
2021 Q3	$35K	Hold	7,887	–	–	﹤0.01%	2386
2021 Q2	$46K	Buy	7,887 +1,500	+23%	+$8.79K	﹤0.01%	2253
2021 Q1	$45K	Hold	6,387	–	–	﹤0.01%	2150
2020 Q4	$31K	Hold	6,387	–	–	﹤0.01%	2267
2020 Q3	$37K	Hold	6,387	–	–	﹤0.01%	2032
2020 Q2	$43K	Buy	6,387 +2,420	+61%	+$18.3K	﹤0.01%	1930
2020 Q1	$25K	Hold	3,967	–	–	﹤0.01%	2063
2019 Q4	$41K	Hold	3,967	–	–	﹤0.01%	2035
2019 Q3	$16K	Hold	3,967	–	–	﹤0.01%	2524
2019 Q2	$59K	Hold	3,967	–	–	﹤0.01%	1834
2019 Q1	$98K	Hold	3,967	–	–	﹤0.01%	1487
2018 Q4	$71K	Hold	3,967	–	–	﹤0.01%	1607
2018 Q3	$117K	Hold	3,967	–	–	0.01%	1452
2018 Q2	$180K	Buy	3,967 +242	+6%	+$11.8K	0.01%	1126
2018 Q1	$197K	Hold	3,725	–	–	0.01%	1080
2017 Q4	$253K	Hold	3,725	–	–	0.01%	976
2017 Q3	$283K	Hold	3,725	–	–	0.01%	901
2017 Q2	$349K	Buy	3,725 +655	+21%	+$40.1K	0.02%	837
2017 Q1	$195K	Buy	+3,070	New	+$187K	0.01%	1077

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Ameritas Investment Partners's CLVS Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Clovis Oncology, Inc. (CLVS) in Q2 2022, closing a stake of 7,887 shares — an estimated $16K sold.

Ameritas Investment Partners first reported a position in CLVS in Q1 2017 and held it in 21 quarters. The position peaked at $349K in Q2 2017. 115 funds tracked by Wall St. Rank hold CLVS as of Q2 2022.

Ameritas Investment Partners reported no remaining Clovis Oncology, Inc. position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 7,887 Clovis Oncology, Inc. shares in Q2 2022, an estimated $16K.
Ameritas Investment Partners first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 21 quarters.
Ameritas Investment Partners's Clovis Oncology, Inc. position peaked at $349K in Q2 2017.
115 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.